Evidence map›Paper›PMID 37192162›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Influenza A virus exploits transferrin receptor recycling to enter host cells.

Beryl Mazel-Sanchez, Chengyue Niu, Nathalia Williams, Michael Bachmann, Hélèna Choltus, Filo Silva, Véronique Serre-Beinier, Wolfram Karenovics, Justyna Iwaszkiewicz, Vincent Zoete and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. mBio · 2026
    Article
  7. Article
  8. Cell entry mechanisms of porcine enteric coronaviruses.The Journal of biological chemistry · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Epigallocatechin-3-gallate inhibits replication of influenza A virus via restoring the host methylated genes following infection.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Beryl Mazel-SanchezDepartment of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.ORCID 0000-0001-5446-3017
Chengyue NiuDepartment of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
Nathalia WilliamsDepartment of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.ORCID 0000-0003-2279-5302
Michael BachmannDepartment of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
Hélèna CholtusDepartment of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.ORCID 0000-0002-7557-7029
Filo SilvaDepartment of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.ORCID 0000-0001-8282-4772
Véronique Serre-BeinierThoracic Surgery, Geneva University Hospitals, 1205 Geneva, Switzerland.
Wolfram KarenovicsThoracic Surgery, Geneva University Hospitals, 1205 Geneva, Switzerland.
Justyna IwaszkiewiczMolecular Modeling Group, Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.ORCID 0000-0003-3494-589X
Vincent ZoeteMolecular Modeling Group, Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
Laurent KaiserDepartment of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.ORCID 0000-0002-0857-2252
Oliver HartleyDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
Bernhard Wehrle-HallerDepartment of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.ORCID 0000-0002-1159-1147
Mirco SchmolkeDepartment of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.ORCID 0000-0002-2491-3029
University of Geneva · CHSIB Swiss Institute of Bioinformatics · CHUniversity Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza A virus (IAV) enters host cells mostly through clathrin-dependent receptor-mediated endocytosis. A single bona fide entry receptor protein supporting this entry mechanism remains elusive. Here we performed proximity ligation of biotin to host cell surface proteins in the vicinity of attached trimeric hemagglutinin-HRP and characterized biotinylated targets using mass spectrometry. This approach identified transferrin receptor 1 (TfR1) as a candidate entry protein. Genetic gain-of-function and loss-of-function experiments, as well as in vitro and in vivo chemical inhibition, confirmed the functional involvement of TfR1 in IAV entry. Recycling deficient mutants of TfR1 do not support entry, indicating that TfR1 recycling is essential for this function. The binding of virions to TfR1 via sialic acids confirmed its role as a directly acting entry factor, but unexpectedly even headless TfR1 promoted IAV particle uptake in

Indexed as

Influenza A virusTransferrinEndocytosisReceptors, TransferrinVirus InternalizationReceptors, TransferrinTransferrinantiviralendocytosisinfluenza A virusrecyclingtransferrin receptor 1

Identifiers

PMID37192162
PMCPMC10214170
OpenAlexW4376872648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.